A systematic review and meta-analysis finds that weight-loss interventions are associated with decreased psoriasis severity ...
And the most recent article came out of JAMA in 2024, and they found that for every 1 g increase in urinary sodium, you ...
FibroBiologics is pursuing a development program for CYPS317 with the goal of advancing first-in-human clinical trials following FDA review of the IND filing. The IND submission includes comprehensive ...
In the second half of his Maui Derm recap, George Martin, MD, founder and program director of the meeting, highlights new ...
Researchers have uncovered a previously unrecognized role for immune cell surface sugars in driving inflammation in psoriasis. Scientists have refined how they understand the role of sugars called ...
Oral roflumilast showed potential as a nonbiologic systemic therapy for moderate to severe psoriasis, offering an alternative ...
Takeda Pharmaceutical Co. announced that its oral psoriasis drug zasocitinib proved safe and effective in late-stage trials, ...
Japan's Takeda Pharmaceutical said on Thursday its experimental pill for a type of skin disease, developed using artificial ...
People with psoriasis often describe an itchy sensation that burns and is painful. Most people with psoriasis experience itchiness, but there are ways to manage this symptom. People with psoriasis ...
Takeda reports positive Phase 3 data for psoriasis drug zasocitinib, beating placebo and Otezla, with rapid PASI responses ...
Psoriasis is a chronic, immune-mediated condition. It typically affects the skin, but can also have implications for other organ systems, including the joints. When psoriasis affects the skin, it ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback